Cancer-associated fibroblasts promote osimertinib resistance in non-small cell lung cancer cells via METTL1-mediated NET1 m7G modification | Cell Death & Disease

Nature·Feb 21

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research suggests that cancer-associated fibroblasts play a role in promoting resistance to certain drugs in non-small cell lung cancer cells. The mechanisms of this resistance are being explored, with studies investigating various factors, including metabolic dysregulation and interactions between cancer cells and fibroblasts. The findings may reveal potential therapeutic targets for treating non-small cell lung cancer.

Full coverage

Propionate metabolism is dysregulated in non-small cell lung cancer patients and EGFR-mutant drug-tolerant persister cells

Nature·Mar 18

Transitional CXCL14+ cancer‐associated fibroblasts enhance tumour metastasis and confer resistance to EGFR‐TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma

Wiley Online Library·Mar 31

Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance

Frontiers·May 16

IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cells

Science | AAAS·Aug 16

Exosome, an important transmitter in the drug resistance of non-small cell lung cancer

Frontiers·Apr 28

Cancer-Associated Fibroblasts: Origin, Classification, Tumorigenicity, and Targeting for Cancer Therapy

Wiley Online Library·Oct 28

Rosmarinic acid potentiates gefitinib in lung adenocarcinoma by modulating interactions between cancer cells and cancer-associated fibroblasts

Nature·Jul 6

The clinical significance and potential therapeutic target of tumor-associated macrophage in non-small cell lung cancer

Frontiers·Mar 27

View original report at Nature ↗

Fetching the latest headlines…